Your browser doesn't support javascript.
loading
First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis.
Couroux, Peter; Farias, Paulina; Rizvi, Leena; Griffin, Katherine; Hudson, Christie; Crowder, Timothy; Tarran, Robert; Tullis, Elizabeth.
Afiliación
  • Couroux P; Inflamax Research Limited, Mississauga, Ontario, Canada.
  • Farias P; Spyryx Biosciences, Inc, Durham, NC, USA.
  • Rizvi L; Toronto Adult Cystic Fibrosis Centre, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Griffin K; Toronto Adult Cystic Fibrosis Centre, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Hudson C; Spyryx Biosciences, Inc, Durham, NC, USA.
  • Crowder T; Spyryx Biosciences, Inc, Durham, NC, USA. Electronic address: tcrowder@spyryxbio.com.
  • Tarran R; Marsico Lung Institute, Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, USA.
  • Tullis E; Toronto Adult Cystic Fibrosis Centre, St. Michael's Hospital, Toronto, Ontario, Canada; Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, Canada.
Pulm Pharmacol Ther ; 58: 101819, 2019 10.
Article en En | MEDLINE | ID: mdl-31302339
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Quística / Bloqueadores del Canal de Sodio Epitelial Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Quística / Bloqueadores del Canal de Sodio Epitelial Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article